Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1307163C details a novel synthesis route for potent antifungal intermediates offering high yield and simplified processing for cost-effective pharmaceutical manufacturing.
Novel Lewis acid catalyst enables high yield trimethylacetylhydrazine production reducing costs and simplifying supply chain for global buyers seeking reliable pharmaceutical intermediates.
Patent CN109942553A details a novel one-step asymmetric catalytic route for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN107889504B reveals PRPP-free NMN synthesis. Enhanced enzyme stability and scalability for reliable high-purity nutritional ingredient supply chains.
Patent CN106699756B reveals a stable biocatalytic route for Avibactam. Achieve significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel catalytic synthesis reduces waste and cost. Reliable supply chain for high-purity dye intermediates. Scalable production for global cosmetic and chemical markets.
Patent CN119776314B reveals high-yield enzymatic route. Delivers cost reduction and supply chain reliability for cosmetic and pharmaceutical intermediate manufacturing.
Patent CN110304989A reveals novel synthesis for OLED intermediates. Achieve high purity and cost reduction in electronic chemical manufacturing with scalable processes.
Advanced Lewis acid catalysis for SGLT2 inhibitor intermediates. Reduces waste salt and enhances selectivity for reliable pharmaceutical intermediate supply chains.
Novel synthesis route for 16α-hydroxy prednisolone intermediates offers cost reduction and high purity for pharmaceutical manufacturing supply chains.
Patent CN112679346A reveals a green eutectic solvent method for methyl p-tert-butyl benzoate. Offers cost reduction and supply chain reliability for global buyers.
Patent CN110358752A reveals enzymatic route for high-purity Brivaracetam intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113072456A details a novel copper-catalyzed asymmetric difluoromethylation for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN113461589A details a novel one-step asymmetric Friedel-Crafts reaction yielding high-purity chiral indoleamines with significant cost reduction potential.
Novel patent CN115925616B offers high purity lercanidipine via green catalytic routes ensuring supply chain stability and reduced toxic reagent usage for global buyers
Patent CN116947830A reveals metal-free visible light synthesis for coumarin heterocycles, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced preparation of cyclohexene carboxylates for neuraminidase inhibitors. Optimized route offers cost reduction and scalable manufacturing for API intermediates.
Novel one-step secnidazole preparation improves yield to 60% and reduces solvent use for cost effective pharmaceutical manufacturing supply chains.
Patent CN102660625A details enzymatic synthesis for high purity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN118955504B reveals visible light cobalt catalysis for hexahydro beta carboline indole compounds offering safer greener pharmaceutical intermediate manufacturing supply chain advantages.